CompletedNot Applicable

Digital Twin Smart Educational Platform for Visually Impaired Navigation Training

Egypt30 participantsStarted 2026-01-07

Plain-language summary

This study evaluates a novel digital twin smart educational platform designed to train visually impaired individuals on safe navigation in Saudi urban environments. Independent mobility is challenging for visually impaired people due to dynamic hazards and architectural changes. This interventional study utilizes an advanced computer simulation (digital twin) modeled after real streets in Jeddah, Saudi Arabia. Participants are randomly assigned to either the experimental group (receiving training via the adaptive digital twin platform with 3D spatial audio and wearable haptic feedback) or the control group (receiving traditional orientation and mobility instruction). The training consists of 10 structured sessions over 5 weeks. The primary goal is to determine…

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Certified clinical diagnosis of severe visual impairment or legal blindness. * Aged between 18 and 60 years old. * Physical ability to walk independently and unassisted for at least 15 continuous minutes. * Cognitive and neurological competence to comprehend and interact with multi-modal software telemetry. * Baseline proficiency in using accessibility screen-reader features on mobile devices. Exclusion Criteria: * Profound sensorineural hearing loss or auditory dysfunction that prevents 3D spatial binaural sound localization. * Active upper or lower-limb motor neuropathies that disrupt the perception of haptic micro-actuator vibrations. * History of severe vestibular disorders, severe motion sickness, or inner ear syndromes causing chronic dizziness. * Current participation in concurrent physical orientation and mobility clinical trials.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Real-world Collision Rate (RCR)

Timeframe: At the completion of the 10-session training curriculum (Week 5).

Trial details

NCT IDNCT07641127

SponsorKing Salman Center for Disability Research

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-29

View on ClinicalTrials.gov More Visual Impairment trials